Terms: = Leukemia AND CDKN2C, P42773, 1031, ENSG00000123080, INK4C, p18, p18-INK4C AND Treatment
31 results:
1. All-Cause and Cause-Specific Mortality Among Low-Risk Differentiated Thyroid Cancer Survivors in the United States.
Tran TV; Schonfeld SJ; Pasqual E; Haymart MR; Morton LM; Kitahara CM
Thyroid; 2024 Feb; 34(2):215-224. PubMed ID: 38149602
[No Abstract] [Full Text] [Related]
2. Establishment and validation of a carbohydrate metabolism-related gene signature for prognostic model and immune response in acute myeloid leukemia.
Yang Y; Yang Y; Liu J; Zeng Y; Guo Q; Guo J; Guo L; Lu H; Liu W
Front Immunol; 2022; 13():1038570. PubMed ID: 36544784
[TBL] [Abstract] [Full Text] [Related]
3.
Kayabasi C; Yilmaz Susluer S; Balci Okcanoglu T; Ozmen Yelken B; Mutlu Z; Goker Bagca B; Caliskan Kurt C; Saydam G; Durmuskahya C; Kayalar H; Ozbilgin A; Biray Avci C; Gunduz C
Nutr Cancer; 2022; 74(10):3679-3691. PubMed ID: 35608652
[No Abstract] [Full Text] [Related]
4. Patient-Derived In Vitro and In Vivo Models of Cancer.
Claridge SE; Cavallo JA; Hopkins BD
Adv Exp Med Biol; 2022; 1361():215-233. PubMed ID: 35230691
[TBL] [Abstract] [Full Text] [Related]
5. Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic leukemia Cells after treatment with BTK and MDM2 Pharmacological Inhibitors.
Rimondi E; Melloni E; Romani A; Tisato V; Casciano F; Rigolin GM; Milani D; Celeghini C; Zauli G; Secchiero P; Voltan R
Curr Oncol; 2021 Jul; 28(4):2439-2451. PubMed ID: 34287267
[TBL] [Abstract] [Full Text] [Related]
6. Axolotl
Suleiman S; Di Fiore R; Cassar A; Formosa MM; Schembri-Wismayer P; Calleja-Agius J
Tumour Biol; 2020 Sep; 42(9):1010428320954735. PubMed ID: 32873193
[TBL] [Abstract] [Full Text] [Related]
7. [Safety and efficacy of patients with refractory B-lymphoblastic leukemia treated with anti-CD19 CAR-T cell bridging to allogeneic hematopoietic stem cell transplantation].
Ai H; Yin QS; Wang Q; Fu YW; Wei XD; Song YP
Zhonghua Xue Ye Xue Za Zhi; 2020 Mar; 41(3):239-244. PubMed ID: 32311895
[No Abstract] [Full Text] [Related]
8. The potential health gain and cost savings of improving adherence in chronic myeloid leukemia.
Ector GICG; Govers TM; Westerweel PE; Grutters JPC; Blijlevens NMA
Leuk Lymphoma; 2019 Jun; 60(6):1485-1492. PubMed ID: 30668187
[TBL] [Abstract] [Full Text] [Related]
9. Advance Directive Utilization Is Associated with Less Aggressive End-of-Life Care in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.
Cappell K; Sundaram V; Park A; Shiraz P; Gupta R; Jenkins P; Periyakoil VSJ; Muffly L
Biol Blood Marrow Transplant; 2018 May; 24(5):1035-1040. PubMed ID: 29371107
[TBL] [Abstract] [Full Text] [Related]
10. Optimizing Therapeutic Effect of Aurora B Inhibition in Acute Myeloid leukemia with AZD2811 Nanoparticles.
Floc'h N; Ashton S; Taylor P; Trueman D; Harris E; Odedra R; Maratea K; Derbyshire N; Caddy J; Jacobs VN; Hattersley M; Wen S; Curtis NJ; Pilling JE; Pease EJ; Barry ST
Mol Cancer Ther; 2017 Jun; 16(6):1031-1040. PubMed ID: 28292940
[TBL] [Abstract] [Full Text] [Related]
11. Repression of cdkn2c caused by PML/RARα binding promotes the proliferation and differentiation block in acute promyelocytic leukemia.
Wang X; Tan Y; Li Y; Li J; Jin W; Wang K
Front Med; 2016 Dec; 10(4):420-429. PubMed ID: 27888400
[TBL] [Abstract] [Full Text] [Related]
12. CDKIs p18(ink4c) and p57(Kip2) are involved in quiescence of CML leukemic stem cells after treatment with TKI.
Moreno-Lorenzana D; Avilés-Vazquez S; Sandoval Esquivel MA; Alvarado-Moreno A; Ortiz-Navarrete V; Torres-Martínez H; Ayala-Sánchez M; Mayani H; Chavez-Gonzalez A
Cell Cycle; 2016 May; 15(9):1276-87. PubMed ID: 26985855
[TBL] [Abstract] [Full Text] [Related]
13. A case of simultaneous occurrence of acute myeloid leukemia and multiple myeloma.
Lu-Qun W; Hao L; Xiang-Xin L; Fang-Lin L; Ling-Ling W; Xue-Liang C; Ming H
BMC Cancer; 2015 Oct; 15():724. PubMed ID: 26474569
[TBL] [Abstract] [Full Text] [Related]
14. Hsp90 inhibitor BIIB021 enhances triptolide-induced apoptosis of human T-cell acute lymphoblastic leukemia cells in vitro mainly by disrupting p53-MDM2 balance.
Li M; Zhang X; Zhou WJ; Chen YH; Liu H; Liu L; Yang CM; Qan WB
Acta Pharmacol Sin; 2013 Dec; 34(12):1545-53. PubMed ID: 24241349
[TBL] [Abstract] [Full Text] [Related]
15. Angiopoietin1 contributes to the maintenance of cell quiescence in EVI1(high) leukemia cells.
Ichihara E; Kaneda K; Saito Y; Yamakawa N; Morishita K
Biochem Biophys Res Commun; 2011 Dec; 416(3-4):239-45. PubMed ID: 22033412
[TBL] [Abstract] [Full Text] [Related]
16. NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951.
Clappier E; Collette S; Grardel N; Girard S; Suarez L; Brunie G; Kaltenbach S; Yakouben K; Mazingue F; Robert A; Boutard P; Plantaz D; Rohrlich P; van Vlierberghe P; Preudhomme C; Otten J; Speleman F; Dastugue N; Suciu S; Benoit Y; Bertrand Y; Cavé H;
Leukemia; 2010 Dec; 24(12):2023-31. PubMed ID: 20861920
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic classification of patients with acute lymphoblastic leukemia by using gene copy number profiles identified from array-based comparative genomic hybridization data.
Usvasalo A; Elonen E; Saarinen-Pihkala UM; Räty R; Harila-Saari A; Koistinen P; Savolainen ER; Knuutila S; Hollmén J
Leuk Res; 2010 Nov; 34(11):1476-82. PubMed ID: 20303590
[TBL] [Abstract] [Full Text] [Related]
18. Differential heat shock protein localization in chronic lymphocytic leukemia.
Dempsey NC; Leoni F; Ireland HE; Hoyle C; Williams JH
J Leukoc Biol; 2010 Mar; 87(3):467-76. PubMed ID: 20007907
[TBL] [Abstract] [Full Text] [Related]
19. Kinetics of normal hematopoietic stem and progenitor cells in a Notch1-induced leukemia model.
Hu X; Shen H; Tian C; Yu H; Zheng G; XuFeng R; Ju Z; Xu J; Wang J; Cheng T
Blood; 2009 Oct; 114(18):3783-92. PubMed ID: 19652197
[TBL] [Abstract] [Full Text] [Related]
20. Expression levels of p18ink4c modify the cellular efficacy of cyclin-dependent kinase inhibitors via regulation of Mcl-1 expression in tumor cell lines.
Eguchi T; Itadani H; Shimomura T; Kawanishi N; Hirai H; Kotani H
Mol Cancer Ther; 2009 Jun; 8(6):1460-72. PubMed ID: 19509251
[TBL] [Abstract] [Full Text] [Related]
[Next]
